MeiraGTx Holdings (MGTX) Capital Expenditures (2017 - 2025)
MeiraGTx Holdings' (MGTX) quarterly Capital Expenditures came in at $272000.0 in Q4 2025, down 77.67% YoY from $1.2 million in Q4 2024, and down 55.41% on a QoQ basis from $610000.0 in Q3 2025.
Analysis
MeiraGTx Holdings (MGTX) Capital Expenditures (2017 - 2025) Analysis & Trends
MeiraGTx Holdings (MGTX) has 9 years of Capital Expenditures data on file, last reported at $272000.0 in Q4 2025.
- Quarterly Capital Expenditures fell 77.67% year-over-year to $272000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.8 million (down 22.79% YoY) and the FY2025 annual result came in at $3.8 million, down 22.79% from the prior year.
- Capital Expenditures declined to $272000.0 in Q4 2025, from $610000.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $44.9 million in Q4 2022 to a low of -$26.3 million in Q3 2022.
- A 5-year average of $5.1 million and a median of $2.7 million in 2023 frame the typical range for Capital Expenditures.
- Annual changes were most pronounced in 2022 — Capital Expenditures sank 321.33% — and 2025, when it soared 370.57%.
- Tracing MGTX's Capital Expenditures over 5 years: stood at $24.4 million in 2021, then jumped by 84.05% to $44.9 million in 2022, then tumbled by 96.0% to $1.8 million in 2023, then slumped by 32.11% to $1.2 million in 2024, then plunged by 77.67% to $272000.0 in 2025.
- The last three Capital Expenditures figures came in at $272000.0 (Q4 2025), $610000.0 (Q3 2025), and $1.2 million (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 37.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 2.29 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 25.02 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 34.68 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 251.02 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 6.26 Mn |
| 10 | MeiraGTx Holdings | 1.27 Bn | 1.13 Bn | 315.67 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 272,000.00 |
| Sep 30, 2025 | 610,000.00 |
| Jun 30, 2025 | 1.23 Mn |
| Mar 31, 2025 | 1.71 Mn |
| Dec 31, 2024 | 1.22 Mn |
| Sep 30, 2024 | 730,000.00 |
| Jun 30, 2024 | 1.33 Mn |
| Mar 31, 2024 | 1.68 Mn |
| Dec 31, 2023 | 3.03 Mn |
| Sep 30, 2023 | 3.56 Mn |
| Jun 30, 2023 | 4.98 Mn |
| Mar 31, 2023 | 8.61 Mn |
| Dec 31, 2022 | 8.49 Mn |
| Sep 30, 2022 | 10.01 Mn |
| Jun 30, 2022 | 14.00 Mn |
| Mar 31, 2022 | 12.46 Mn |
| Dec 31, 2021 | 24.37 Mn |
| Sep 30, 2021 | 11.91 Mn |
| Jun 30, 2021 | 5.58 Mn |
| Mar 31, 2021 | 4.50 Mn |